Literature DB >> 1362172

Penetration of fimbriate enteric bacteria through basement membranes: a hypothesis.

T K Korhonen1, R Virkola, K Lähteenmäki, Y Björkman, M Kukkonen, T Raunio, A M Tarkkanen, B Westerlund.   

Abstract

A mechanism for penetration of basement membranes by Escherichia coli is presented. The mechanism is based on the ability of the S fimbriae of meningitis-associated E. coli to bind to vascular endothelium and choroid plexuses in brain and to basement membranes. On the other hand, the S and the type 1 fimbriae of E. coli immobilize plasminogen and tissue-type plasminogen activator; this process generates proteolytic plasmin activity on the surface of fimbriate cells. Our hypothesis is that bacterium-bound plasma activity, directed to basement membranes through fimbrial binding, promotes bacterial penetration through basement membranes.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1362172     DOI: 10.1111/j.1574-6968.1992.tb14057.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  11 in total

1.  The cellular form of human fibronectin as an adhesion target for the S fimbriae of meningitis-associated Escherichia coli.

Authors:  A Sarén; R Virkola; J Hacker; T K Korhonen
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Ability of Escherichia coli isolates that cause meningitis in newborns to invade epithelial and endothelial cells.

Authors:  C Meier; T A Oelschlaeger; H Merkert; T K Korhonen; J Hacker
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Clonal analysis reveals high rate of structural mutations in fimbrial adhesins of extraintestinal pathogenic Escherichia coli.

Authors:  Scott J Weissman; Sujay Chattopadhyay; Pavel Aprikian; Mana Obata-Yasuoka; Yuliya Yarova-Yarovaya; Ann Stapleton; William Ba-Thein; Daniel Dykhuizen; James R Johnson; Evgeni V Sokurenko
Journal:  Mol Microbiol       Date:  2006-02       Impact factor: 3.501

4.  Virulence patterns of Escherichia coli K1 strains associated with neonatal meningitis.

Authors:  E Bingen; S Bonacorsi; N Brahimi; E Denamur; J Elion
Journal:  J Clin Microbiol       Date:  1997-11       Impact factor: 5.948

5.  Bacterial plasminogen receptors: in vitro evidence for a role in degradation of the mammalian extracellular matrix.

Authors:  K Lähteenmäki; R Virkola; R Pouttu; P Kuusela; M Kukkonen; T K Korhonen
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

6.  Expression of plasminogen activator pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix.

Authors:  K Lähteenmäki; R Virkola; A Sarén; L Emödy; T K Korhonen
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

7.  Sialyloligosaccharide chains of laminin as an extracellular matrix target for S fimbriae of Escherichia coli.

Authors:  R Virkola; J Parkkinen; J Hacker; T K Korhonen
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

8.  Comparative structure-function analysis of mannose-specific FimH adhesins from Klebsiella pneumoniae and Escherichia coli.

Authors:  Steen G Stahlhut; Veronika Tchesnokova; Carsten Struve; Scott J Weissman; Sujay Chattopadhyay; Olga Yakovenko; Pavel Aprikian; Evgeni V Sokurenko; Karen Angeliki Krogfelt
Journal:  J Bacteriol       Date:  2009-09-04       Impact factor: 3.490

9.  Identification of two laminin-binding fimbriae, the type 1 fimbria of Salmonella enterica serovar typhimurium and the G fimbria of Escherichia coli, as plasminogen receptors.

Authors:  M Kukkonen; S Saarela; K Lähteenmäki; U Hynönen; B Westerlund-Wikström; M Rhen; T K Korhonen
Journal:  Infect Immun       Date:  1998-10       Impact factor: 3.441

10.  Population variability of the FimH type 1 fimbrial adhesin in Klebsiella pneumoniae.

Authors:  Steen G Stahlhut; Sujay Chattopadhyay; Carsten Struve; Scott J Weissman; Pavel Aprikian; Stephen J Libby; Ferric C Fang; Karen Angeliki Krogfelt; Evgeni V Sokurenko
Journal:  J Bacteriol       Date:  2009-01-16       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.